Parisa Adelhardt
No Rating Available
(Learn About Our Rating System)

Parisa Adelhardt, MD, MSc

Languages spoken: English

  • Board Certification

    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Molecular Genetic Pathology)

  • Board Certification and Academic Information

    Academic Departments Pathology -Associate Professor (Clinical)
    Board Certification
    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Molecular Genetic Pathology)

    Education history

    Fellowship Molecular Genetic Pathology - University of New Mexico School of Medicine Fellow
    Residency Anatomical and Clinical Pathology - University of New Mexico School of Medicine Resident
    Graduate Training Experimental Medicine - McGill University M.Sc.
    Professional Medical Medicine - Tehran University of Medical Sciences School of Medicine M.D.

    Selected Publications

    Journal Article

    1. Wilcock D, Sirohi D, Coleman JF, Adelhardt P, Kim JT, Albertson D, Affolter K, Beech C, Jedrzkiewicz J, Ruano AL, Cleary AS, Mahlow J, Balatico M, Gulbahce HE (2024). HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as positive after targeted recounts following equivocal (2+) immunohistochemistry. Am J Clin Pathol, 163(6), 837-846. (Read full publication)
    2. Beech C, Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim J, Coleman JF, Deftereos G, Gulbahce EH, Sirohi D (2025). Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization. Appl Immunohistochem Mol Morphol, 33(2), 91-102. (Read full publication)
    3. Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Burlingame J, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim JT, Coleman JF, Deftereos G, Gulbahce EH, Sirohi D (2023). Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer. Arch Pathol Lab Med. (Read full publication)